Clinical Trial Update: Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules [Phase 1]

View source ↗

Summary

Phase 1 trial update on using Fludeoxyglucose F-18 PET/CT scans in patients receiving ultra-short-term dexamethasone for lung nodules, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Nodules

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Pulmonary Nodule | Phase 1 | Status: COMPLETED | Results posted: 2014-09-29